The purpose of this access protocol is to allow patients with brain tumors who had previously
received 125I-MAB 425 to receive additional course(s) of 125I-MAB 425 until their brain tumor
begins to grow, they develop side effects to the treatment, or their medical condition
changes (e.g., you become pregnant, become infected with human immunodeficiency virus (HIV)
or develop another cancer).